Can a home device keep cirrhosis patients out of the hospital?
NCT ID NCT02457988
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a home monitoring kit (measuring blood pressure, weight, and pulse) plus care coordination could reduce hospital readmissions in people with cirrhosis. It enrolled 120 patients with serious complications like fluid buildup or confusion. The trial was terminated early, so the findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vivify Kit (home telemonitoring device)
What this could lead to
If successful, this approach could help manage cirrhosis at home and reduce hospital readmissions.
What could go wrong
The trial was terminated early, so results are limited. It is a small, early-phase study, and the device may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA Center for Inflammatory Bowel Diseases
Los Angeles, California, 90095, United States